The data consisted of several smaller independent studies investigating whether serotonin transporter (5-HTT) levels, as measured with PET, are abnormal in patients with Major Depressive Disorder (MDD) compared to healthy controls (HC) (e.g.,Cannon et al., 2007;Miller et al., 2013). This evidence concerns the gene SLC6A4 and major depressive disorder.